Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07197970) titled 'Drug- Eluting Stent for Symptomatic Intracranial Arterial Stenosis' on Sept. 25.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Beijing Tiantan Hospital
Condition:
Symptomatic Intracranial Atherosclerotic Stenosis
Intervention:
Device: NxiDIME™ Intracranial Drug-Eluting Stent System
Recruitment Status: Recruiting
Phase: Phase 3
Date of First Enrollment: May 15, 2025
Target Sample Size: 224
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.go...